ARTICLE | Company News
Genmab cancer news
September 20, 2010 7:00 AM UTC
Genmab announced a revised corporate strategy that includes plans to reduce operating expenses by 20% in 2011 through a reduction in R&D spending. As part of the R&D reductions, Genmab will find a par...